Furthermore, mutations, overexpression or downregulation of PTEN (phosphatase and tensin homolog on chromosome 10) or EGFR (epidermal growth factor (EGF) receptor), both common in glioblastomas, are possible modulators of Akt activation or negative regulation [82,83,84]. The gene discussed is AKT1; the disease is glioblastoma.